Metagen Therapeutics, Inc.
PrivateLast Round
Series B
Sep 8, 2025
Total Funding Raised
$27.97M
Momentum Score
25 /100
Company Overview
Metagen Therapeutics, Inc. is a biotech company that advances medicine and drug discovery based on the human gut microbiome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Metagen Therapeutics, Inc. Comps
Public and private peers based on sector, stage, and business model.
Metagen Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 8, 2025 | ||||
| Series A | Jun 15, 2023 | ||||
| Seed | Mar 17, 2021 |
Key People
Founding team and executive leadership
Metagen Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JAFCO Group Co., Ltd. | Series A |
| Sparx Asset Management | Series A |
| Keio Innovation Initiative | Seed, Series A |
| Mizuho Capital | Series A |
| 日本ベンチャーキャピタル株式会社 | Series A |
| Dentsu Ventures | Series B |
| JIC Venture Growth Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2025
Company is in the N-2 stage, indicating a potential listing in approximately two years.
- Nov 10, 2025
Partnering with Juntendo University for ulcerative colitis research.
Metagen Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Metagen Therapeutics, Inc.'s valuation, stock price, and market status.
